THURSDAY 16 MARCH 2023
< back to program overview Program Friday 17 March 2023 >
09:00-09:10 |
WELCOME AND OPENING
|
|
|
|
|
09:10-10:10 |
PLENARY 1: CHANGES SOCIETIES
|
|
|
History of the different pediatric societies |
|
New way of working: Belgian Academy of Pediatrics |
||
Panel discussion with voting system, Q&A |
||
10:10-11:00 |
COFFEE BREAK |
|
10:30-11:00 | POSTER WALK INFECTIOLOGY, PNEUMOLOGY & IMMUNOLOGY (PW1 - PW10) |
|
Posterwalk overview | ||
10:30-11:00 |
SATELLITE SYMPOSIUM SANOFI |
|
PREVENTION LANDSCAP IN RSV | ||
- Existing needs in RSV prevention - Current strategies in the prevention landscape for RSV disease in infants - Future strategies and approaches for preventing RSV disease in infants |
||
10:30-11:00 | BPCRN SESSION | |
Dose adaptation in critical ill children P. Decock |
||
Drug exposure via human milk: Current status and research initiatives Anne Smits, UZ Leuven |
||
BPCRN within the Connect4Children (C4C) clinical trial network: an update Eva Degraeuwe, UZ Gent Johan Vande Walle, UZ Gent |
||
11:00-12:30 |
PARALLEL SUBSPECIALITY SESSIONS |
|
A. CARDIOLOGY & INFECTIOLOGY |
||
Results of the Belvasco registry on PIMS in Belgium |
||
Long term cardiac residual lesions after PIMS (COVID) |
||
Cardiac risks of vaccination : COVID and non-COVID |
||
Could this be cardiac disease? (Infections and the heart) |
||
The new national malaria protocol |
||
B. HEMATOLOGY/ONCOLOGY/IMMUNOLOGY & REUMATOLOGY Chairs: Pierre Philippet (CHC MontLégia) |
||
Primary and secondary HLH, multidisciplinary point of view |
||
Ethical issues in incidental findings with expanding NGS testing Robin De Putter, UZ Gent |
||
Puzzling clinical pictures across boundaries |
||
|
C. NEUROLOGY/RADIOLOGY/METABOLICS Chairs: Luc Régal (UZ Brussel) |
|
Treatable metabolic disorders |
||
Neonatal brain imaging |
||
Ethical considerations in newborn screening |
||
Update on SMA |
||
Questions |
||
D. DERMATOLOGY & GENETICS Chairs: Kathelijn Keymolen (UZ Brussel) & Dirk Van Gysel (OLVZ Aalst) |
||
Cutaneous clues to type 1 interferonopathies |
||
Pediatric dermatology: from phenotype to genotype, and back Dirk Van Gysel, OLVZ Aalst |
||
Genetics of vascular malformations Nicole Revencu, UCL |
||
Cutis Laxa Bert Callewaert, Universiteit Gent |
||
Differential diagnosis of café-au-lait spots Eric Legius, UZ Leuven |
||
|
|
|
12:30-13:30 |
LUNCH AND POSTERS |
|
12:45-13:30 |
SATELLITE SYMPOSIUM TRUVION HEALTHCARE NV |
|
Postbiotics in acute gastro-enteritis: Back to Basics Yvan Vandenplas, UZ Brussel |
||
13:00-13:30 |
POSTER WALK CARDIOLOGY, HEMATO-ONCOLOGY, NEUROLOGY & NEONATOLOGY-PICU (PW11 - PW20) |
|
Posterwalk overview | ||
13:30-14:45 |
PARALLEL SESSIONS |
|
NURSES SESSION Chairs: Sofie Moreels (UZ Gent) |
||
The role of the clinical nurse specialist and the nurse practitioner at the children’s hospital in UZ Gent Sofie Moreels & Benjamin De Ridder, UZ Gent |
||
LONG ORAL PRESENTATIONS 1 (LO 1–LO 6) Chairs: Benoit Florkin (CHR de la Citadelle) & Tyl Jonckheer (VBS) |
||
LO 1. Drug exposure at the target site: are children a neglected population in tissue pharmacokinetic research ? |
||
LO 2. Isolated chronic fetal hypoxia results in delayed lung development and maturation using an extrauterine womb lamb model |
||
LO 3. Serum cytokines differentiate among patients with multiple inflammatory diseases: proof-ofconcept data for FEBRIS, a multi-centric prospective study |
||
LO 4. Does air pollution affect the airways of early-career elite athletes? |
||
LO 5. Higher drug exposure to infliximab correlates with rate of anti-TNF induced skin lesions in paediatric IBD patients |
||
LO 6. The clinical spectrum and biological findings in RAS-associated juvenile myelomonocytic leukemia and RAS-associated lymphoproliferative disorder |
||
SHORT ORAL PRESENTATIONS 1 (SO 1 - SO 12) Chairs: Nathalie Godefroid (UCL) & Daniel Klink (ZNA) |
||
SO 1. The European Paediatric Clinical Trials Network conect4children (c4c): 5-year report of activities within Belgium |
||
SO 2. The Challenges in performing Pediatric Clinical Trials: an update after 15-years of EMA Regulation |
||
SO 3. Elimination of rubella in Belgium |
||
SO 4. Qualitative research to increase participation and quality of surveillance networks |
||
SO 5. Solving the puzzle of MEN2B syndrome in an adolescent girl |
||
SO 6. A monoallelic AIRE gene mutation in a female adolescent with “ isolated “ hypoparathyroidism and high levels of anti-IFNα auto-antibodies |
||
SO 7. Monitoring quality of rehabilitation using a new evaluation instrument: Patient Reported Experience Measures (PREMs). |
||
SO 8. Three families with TSH resistance and different clinical presentations |
||
SO 9. The impact of chronic kidney disease on the renal circadian rhythms in children |
||
SO 10. Copeptin as a predictive biomarker for desmopressin response in children with enuresis |
||
SO 11. Risk and management of an acute aminoglycoside overdose: case report and literature review |
||
SO 12. Navigating the Unknown: Understanding and Managing Parental Anxiety When a Child is ill |
||
VVK/GBPF SESSION: FOCUS ON THE FIRST 1000 DAYS OF LIFE Chairs: Ruth Heying (VVK) & Françoise Mascart (GBPF) |
||
Nutrition: new formula's/Breast feeding/nutrition fo children below the age of 3 Ellen Peeters, VVK Evelien Snoeck, ZNA |
||
Ophtalmological screening in a very young patients. Facing the Myopia Epidemic. Nathalie Schaeken, Ophtalmopediatric Myopia working group |
||
New presentations in dermatology Hannelore De Maeseneer, Belgian Pediatric Dermatology Association |
||
14:45-15:00 |
MINI BREAK |
|
15:00-16:15 |
PARALLEL SESSIONS |
|
SHORT ORAL PRESENTATIONS 2 (SO 13 - SO 24) Chairs: Koen Huysentruyt (UZ Brussel) & Jean-François Questiaux (CHR Verviers) |
||
SO 13. Decompensated vasoreactive pulmonary arterial hypertension following erroneous calcium channel antagonist magistral preparation |
||
SO 14. Evaluation of Late Cardiac Effects After Multisystem Inflammatory Syndrome in Children |
||
SO 15. Inotuzumab ozogamicin as a bridge to hematopoietic stem cell transplantation in relapsed pediatric BCP-ALL after CD19-targeted CAR T-cell therapy |
||
SO 16. Retrospective study on the epidemiology of vincristine-induced peripheral neuropathy in patients with pediatric solid tumors |
||
SO 17. Chronic myeloid leukemia in children and adolescents – clinicopathological results of a monocentric retrospective study |
||
SO 18. Retrospective study of children with chronic myeloid leukemia treated in Belgium between 2000 and 2021 |
||
SO 19. Poorly differentiated thyroid carcinoma in children and adolescents: a very rare type of thyroid tumor related to DICER1 mutation. |
||
SO 20. Missed diagnoses of seasonal Eosinophilic Esophagitis? |
||
SO 21. Self-reported prescribing behaviour of vitamin D Prophylaxis in healthy children by Belgian Paediatricians |
||
SO 22. Handgrip strength as a parameter of health outcome in hospitalized children or children with chronic disease |
||
SO 23. Does the new Dutch norms of the Alberta Infant Motor Scale better predict motor outcome in a Belgian preterm population? A 2 years follow-up study. |
||
SO 24. Invasive Group A streptococcal disease in a Tertiary Centre Paediatric Intensive Care Unit: an 8- year prospective cohortstudy. |
||
VVK/GBPF SESSION: FOCUS ON THE FIRST 1000 DAYS OF LIFE |
||
Psychoperinatality: a new challenge in mental health prevention |
||
16:15-16:45 |
COFFEE BREAK |
|
|
|
|
16:45-18:00 |
PLENARY 2: MAKING THE RIGHT CHOICES Chair: Myriam Van Winckel (UZ Gent) & Christophe Barrea (CHR de la Citadelle) |
|
Prevention of burn out in pediatrics |
||
Choosing wisely: overuse of medical care in pediatrics |